Resources

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Continuous Subcutaneous Insulin Infusion (CSII) PEDIATRICS David Maahs, MD, PhD, and H. Peter Chase, MD Standard of Care A consensus statement on the use of insulin pump therapy, CSII, in youth with type 1 diabetes (T1D) …

PROTECT iT – The Intelligent Texture Sock    Therapeutic diabetic socks help to relieve discomfort, provide warmth, and prevent bacterial growth. PROTECT iT, the "Intelligent Texture" sock has multi-zone construction providing increased protection for sore-prone areas with silver ions within the fibers to inhibit bacterial growth, fungus and odor.   

A potential new treatment option for T2 diabetes…. 

New preliminary data is in…. Sanofi, the maker of Lantus (insulin glargine), finished more phase III studies on their newest formulation of insulin glargine, U300, and discussed their results at the World Diabetes Congress 2013 in early December. The study results have not yet been published but researchers reported that the …

Post market study results…. 

What the studies really say…. 

Blueberries, grapes, and apples may show benefit in type 2 diabetes…. 

Should it be used in treating type 2 diabetes?… 

Is it enough?… 

Tolerability in type 2 diabetes patients aged 65 years and older….